Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28218450 | 0.93 | RAB9A (0.49) | ALDH1A1PARP14PARP10LMNAHPGD | |
| SCHEMBL4615095 | 0.84 | NPC1 (0.45) | ALDH1A1PARP14PARP10 | |
| SCHEMBL3312540 | 0.83 | ALDH1A1 (0.62) | ALDH1A1TSHRLMNAHPGDHIF1A | |
| SCHEMBL1995415 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNAHPGDHIF1A | |
| SCHEMBL3737773 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TSHRLMNAHPGDHIF1A | |
| SCHEMBL1439746 | 0.81 | PDE4B (0.51) | — | |
| SCHEMBL21359167 | 0.80 | PROKR1 (0.62) | ALDH1A1TSHRLMNAHPGDHIF1A | |
| SCHEMBL23123210 | 0.79 | HDAC1 (0.47) | ALDH1A1TSHRLMNAHPGDHIF1A | |
| SCHEMBL14151219 | 0.78 | HDAC1 (0.46) | HSD11B1PROKR1 | |
| SCHEMBL14151217 | 0.78 | HDAC1 (0.46) | HSD11B1PROKR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101039904-B | Is suitable for treating dopamine D3Heterocyclic compounds for receptor-modulated responsive disorders | ABBOTT GMBH & CO KG | 2014-09-24 | — | — | CN | disclosed |
| EP-2473049-A1 | BRUTON'S TYROSINE KINASE INHIBITORS | Biogen Idec MA Inc. (US) | 2012-07-11 | — | — | EP | disclosed |
| WO-2011029046-A1 | BRUTON'S TYROSINE KINASE INHIBITORS | BIOGEN IDEC MA INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| CN-101039904-A | Is suitable for treating dopamine D3Heterocyclic compounds for receptor-modulated responsive disorders | ABBOTT GMBH & CO KG (DE) | 2007-09-19 | — | — | CN | disclosed |